Posttraumatic Stress Symptoms Sample Clauses

Posttraumatic Stress Symptoms. The Posttraumatic Stress Disorder Checklist (PCL-S) (XxXxxxxx et al. 2016)24 15-25 AYAs = 0.91, Parents = 0.92 - - Xxxxxxx Psychological Dis- tress Scale (K10) (XxXxxxxx et al. 2016)24 15-25 AYAs= 0.93 parents= 0.94 - - The Multidimensional Scale of Perceived Social Support (MSPSS) (XxXxxxxx et al. 2016)24 15-25 0.94 - - Medical Outcomes Social Support Survey (MOS) (XxXxxxxx et al. 2016)24 15-25 0.96 - - Hospital Anxiety and Depression Scale (HADS) (Xxxxxx et al. 1998)39 12-19 - Case requiring further attention= 75%, Cases with depressive symptomology= 67%, DSM-IV diagnosis= 67%, DSM-IV depressed mood disorder= 50% Case requiring further attention= 74%, Cases with depressive symptomology= 70%, DSM-IV diagnosis= 70%, DSM-IV depressed mood disorder= 67% Xxxx Depression Inventory (BDI) (Xxxxxx et al. 1998)39 12-19 - Case requiring further attention= 50%, Cases with depressive symptomology= 50%, DSM-IV diagnosis= 40%, DSM-IV depressed mood disorder= 33% Case requiring further attention= 58%, Cases with depressive symptomology= 57%, DSM-IV diagnosis= 56%, DSM-IV depressed mood disorder= 41% Rotterdam Symptom Checklist (RSCL) (Xxxxxx et al. 1998)39 12-19 - Case requiring further attention= 63%, Cases with depressive symptomology= 83%, DSM-IV diagnosis= 50%, Case requiring further attention= 89%, Cases with depressive symptomology= 89%, DSM-IV diagnosis= 84%, Measure (Reference) Age range of TYA cancer population that measure was validated in Internal Consistency (Cronbach Alpha) Sensitivity Specificity DSM-IV depressed mood disorder= 75% DSM-IV depressed mood disorder= 85% Brief Symptom Inventory-18 (BSI-18) (Xxxxxxx et al. 2014)32 15-39 0.90 - - Interview for disease and treatment distress (no official name) (Xxxxxxxx et al. 2006)34 13-19 - Physical concerns: Infections- physicians-59%, nurses- 64%, Mucositis- 60%, 59%, Nausea- 71%, 79%, Pain from disease-71%, 44%, Pain from procedures/treatments- 60%,62% Personal changes: Changed temper- 60%, 46%, Fatigue-84%, 80%, Hair loss-84%, 86%, Round face-52%, 67%, Weight loss/gain-49%, 76% Feelings of alienation: Experiencing lower self-esteem-0%, 33%, Feeling different than friends-73%, 40%, Feeling left-out by friends- 29%, 56%, Missing leisure activities- 60%, 100%, not wanting others to see me- 11%, 44% Disease- and treatment-related worries: Worry about being left-out by friends-0%, 57%, Physical concerns: Infections- physicians-84%, nurses- 61%, Mucositis- 83%, 83%, Nausea- 77%, 53%, Pain from disease-79%, 49%, P...
AutoNDA by SimpleDocs
Posttraumatic Stress Symptoms. Posttraumatic stress symptoms are varied and can include intrusive re-experiencing aspects of the traumatic event, avoidance of reminders of the event or a numbing of emotions, and hypervigilance or increased physiological arousal. In order to meet the DSM-IV-TR (American Psychiatric Association, 2000) criteria for Posttraumatic Stress Disorder (PTSD), an identifiable stressor that is potentially life-threatening needs to be defined and the content of the symptoms should refer the stressor (Breslau, Chase, & Xxxxxxx, 2002). According to DSM-IV-TR, an individual must have experienced an event in which both of the following are present: 1) the person experienced, witnessed, or was confronted with an event or events that involved actual or threatening death or serious injury, or a threat to the physical integrity of self or others; 2) the person’s response involved intense fear, helplessness, or horror (Criteria A). Posttraumatic stress symptoms on their own, without being connected to a stressor, would not meet criteria for a PTSD diagnosis and instead may be indicative of other emotional disorders, such as anxiety or depression, which can overlap with PTSD (Xxxxxx, Xxxxxxxxx, Xxxxx, & Xxxxx, 1997). Although the DSM-IV indicates that significant others can also be significantly affected by a traumatic event that they witness or learn of, PTSD diagnostic criterion has been criticised for being too restrictive (Power & Xxxxxxxxx, 1997) and for failing to acknowledge the psychological impact of interpersonal trauma such as childhood abuse (Xxxxx, 2001) or psychosis (Shaw, XxXxxxxxx, & Xxxxxxxx, 1997). If we consider caregiving relationships, it is possible that the current operational definitions of PTSD in DSM-IV will also fail to capture potentially traumatic stressors that are commonly experienced by carers of people with psychosis. It could be argued, for example, that non-life threatening, objective events such as police involvement in the pathway to treatment, compulsory detainment under the Mental Health Act (1983), and psychotic behaviour in a loved relative, may be related to posttraumatic stress symptoms observed in people who care for someone with psychosis. Genuine traumatic symptoms may be missed and theoretical developments restricted, if research adheres rigidly to current criterion (Xxxxxxx, Xxxxx, Xxxxxx, & Xxxxxxxxx, 2004). There are several reports of people exhibiting full PTSD symptoms, without the direct experience of acute precipitating t...
Posttraumatic Stress Symptoms. Posttraumatic stress total scores for the Impact of Events Scale – Revised (IES-R; Xxxxx & Xxxxxx, 1997) ranged within the sample from 0 to 3.05 (M = 1.32, SD = .87). Almost half (n = 14, 44%) had a total score greater than 1.5 on the IES-R. The IES-R correlates highly with the PTSD checklist (PCL), suggesting that scores >1.5 provide optimum diagnostic accuracy against the PCL (Xxxxxxx et al., 2003). Table 4 presents mean scores for IES-R total and subscale scores. According to the SCID interview, one participant (3%) met full diagnostic criteria for PTSD in response to an event related to their caring role. Table 4 Avoidance 1.48 .96 Hyperarousal 1.26 1.00 Intrusion 1.23 .84 IES-R Total 1.33 0.88 Approximately half of the carers completed the IES-R in relation to a specific traumatic event related to the caring role (n = 15, 47%). Despite experiencing stressful life events related to the caring role, the remainder of carers (n = 17, 53%) completed the IES-R in relation to the caring role in general because one specific event could not be identified as the most upsetting or traumatic. A Xxxx-Xxxxxxx U test was conducted to compare posttraumatic stress symptom scores (as measured by the IES-R) for these two groups (i.e., those who rated the IES-R in relation to the caring role in general and those that rated it in relation to a specific event associate with their caring role). No significant difference was found in posttraumatic stress symptoms (IES-R total score) of those participants who rated the IES-R in relation to the caring role in general (Md = 1.14; n = 17) and those who rated the IES-R in relation to a specific event associated with the caring role (Md = 1.36; n = 15, U = 103, z = -.93, p = .36, r = 0.17. Xxxx-Xxxxxxx U tests were also used to compare the two groups of carers on all other measures. The only significant difference between the two groups was on a measure of anxiety (HADS). A Xxxx-Xxxxxxx U Test revealed a significant difference in anxiety level (as rated by the HADS) of carers who completed the IES-R in relation to the caring role in general (Md = 7, n = 16) and those who rated the IES-R in relation to a specific event (Md = 10, n = 15), U = 64.5, z = -2.20, p = .03, r = 0.39. Carers indicated that they had experienced or witnessed a range of stressful life events related to their caring role (see Table 5). 77% of the sample (n = 24) reported that they had also experienced or witnessed a traumatic event in their life unrelated to t...
Posttraumatic Stress Symptoms physical health and sleep in carers of people with psychosis

Related to Posttraumatic Stress Symptoms

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Organ Transplants This plan covers organ and tissue transplants when ordered by a physician, is medically necessary, and is not an experimental or investigational procedure. Examples of covered transplant services include but are not limited to: heart, heart-lung, lung, liver, small intestine, pancreas, kidney, cornea, small bowel, and bone marrow. Allogenic bone marrow transplant covered healthcare services include medical and surgical services for the matching participant donor and the recipient. However, Human Leukocyte Antigen testing is covered as indicated in the Summary of Medical Benefits. For details see Human Leukocyte Antigen Testing section. This plan covers high dose chemotherapy and radiation services related to autologous bone marrow transplantation to the extent required under R.I. Law § 27-20-60. See Experimental or Investigational Services in Section 3 for additional information. To speak to a representative in our Case Management Department please call 1-401- 000-0000 or 1-888-727-2300 ext. 2273. The national transplant network program is called the Blue Distinction Centers for Transplants. SM For more information about the Blue Distinction Centers for TransplantsSM call our Customer Service Department or visit our website. When the recipient is a covered member under this plan, the following services are also covered: • obtaining donated organs (including removal from a cadaver); • donor medical and surgical expenses related to obtaining the organ that are integral to the harvesting or directly related to the donation and limited to treatment occurring during the same stay as the harvesting and treatment received during standard post- operative care; and • transportation of the organ from donor to the recipient. The amount you pay for transplant services, for the recipient and eligible donor, is based on the type of service.

  • Meteorological Data Reporting Requirement (Applicable to wind generation facilities only)

  • C-TPAT In connection with providing Goods and Services to AGILENT, Seller shall comply with Customs-Trade Partnership Against Terrorism (C- TPAT) or equivalent supply chain security measures. When requested by AGILENT, Seller shall demonstrate compliance by providing certification thereof to AGILENT.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!